For instance, Oberli et al.159 reported a lipid NP formulation loaded with the tumor-associated antigens gp100 and TRP2 for the delivery of mRNA vaccines to induce a cytotoxic CD8 T-cell response. The gene discussed is CD8A; the disease is neoplasm.